A detailed history of Vaughan Nelson Investment Management, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Vaughan Nelson Investment Management, L.P. holds 88,670 shares of PFE stock, worth $2.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
88,670
Previous 76,850 15.38%
Holding current value
$2.34 Million
Previous $2.15 Million 19.35%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $327,414 - $371,029
11,820 Added 15.38%
88,670 $2.57 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $184,998 - $216,245
5,765 Added 8.11%
76,850 $2.55 Million
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $220,512 - $255,127
-6,105 Reduced 7.91%
71,085 $2.61 Million
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $563,670 - $733,816
-14,310 Reduced 15.64%
77,190 $3.15 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $99,156 - $129,437
2,375 Added 2.66%
91,500 $4.69 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $681,675 - $844,681
14,900 Added 20.07%
89,125 $4.61 Million
Q3 2021

Oct 27, 2021

BUY
$39.25 - $50.42 $306,150 - $393,276
7,800 Added 11.74%
74,225 $3.19 Million
Q2 2021

Jul 15, 2021

BUY
$35.91 - $40.68 $201,095 - $227,808
5,600 Added 9.21%
66,425 $2.6 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $24,280 - $27,383
725 Added 1.21%
60,825 $2.2 Million
Q4 2020

Feb 04, 2021

BUY
$33.47 - $42.56 $831,729 - $1.06 Million
24,850 Added 70.5%
60,100 $2.21 Million
Q4 2017

Jan 26, 2018

BUY
$33.26 - $35.29 $458,988 - $487,002
13,800 Added 64.34%
35,250 $1.28 Million
Q3 2017

Oct 24, 2017

BUY
$31.0 - $34.15 $664,950 - $732,517
21,450
21,450 $766,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.